Research study Program year 2025 Source: CMS Open Payments

A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Dose-Ranging Study to Evaluate the Efficacy and Safety of Tak-101 for the Prevention of Gluten-Specific T Cell Activation in Subjects With Celiac Disease on A Gluten-Free Diet

ClinicalTrials.gov NCT04530123

Research payments

$4,592,083

1,811 payments

Through program year 2025, $4,592,083 in research payments was reported against A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Dose-Ranging Study to Evaluate the Efficacy and Safety of Tak-101 for the Prevention of Gluten-Specific T Cell Activation in Subjects With Celiac Disease on A Gluten-Free Diet, across 1,811 payments, paid by Takeda Pharmaceuticals U.S.A., Inc..

Paid by: Takeda Pharmaceuticals U.S.A., Inc.
ClinicalTrials.gov: NCT04530123

By program year

5 rows

Year	Kind	Amount	Payments
2025	Research	$3,770,788	1,570
2024	Research	$294,742	68
2023	Research	$161,325	44
2022	Research	$178,544	61
2021	Research	$186,684	68

Breakdown

Who paid Research payments · program years 2021–2025

Takeda Pharmaceuticals U.S.A., Inc. $4,592,083 1,811 payments

Who received the money Research payments · program years 2021–2025

Basil Clinical Co Organisation paid for research $1,770,966 567 payments
Beth Israel Deaconess Medical Center Teaching hospital · MA $389,661 160 payments
Mayo Clinic Hospital Rochester Teaching hospital · MN $336,644 36 payments
University Gastroenterology LLC Organisation paid for research $281,975 100 payments
One Of A Kind Clinical Research Center LLC Organisation paid for research $276,684 132 payments
Clinical Research Institute Of Michigan LLC Organisation paid for research $111,036 136 payments
Rockford Gastroenterology Associates Ltd Organisation paid for research $94,519 72 payments
Care Access Research LLC Organisation paid for research $89,162 67 payments
Gastroenterology And Liver Institute Organisation paid for research $89,067 30 payments
Agile Clinical Research Trials LLC Organisation paid for research $80,360 60 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.

Cite this record

“A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Dose-Ranging Study to Evaluate the Efficacy and Safety of Tak-101 for the Prevention of Gluten-Specific T Cell Activation in Subjects With Celiac Disease on A Gluten-Free Diet”, Who Paid My Doc, citing CMS Open Payments, program year 2025. https://www.whopaidmydoc.com/research-studies/a-randomized-double-blind-placebo-controlled-phase-2-dose-ranging-study-to-evaluate-the-efficacy-and-safety-of-tak-101-for-the-prevention-of-gluten-specific-t-cell-activation-in-subjects-with-celiac-disease-on-a-gluten-free-diet-60073047

Figures here may be reproduced with attribution and a link — see for journalists and researchers.